Literature DB >> 6795230

Selective effects of glucocerebroside (Gaucher's storage material) on macrophage cultures.

I Gery, J S Zigler, R O Brady, J A Barranger.   

Abstract

Although the enzymatic lesion in Gaucher's disease is well established, little is known concerning the pathogenic mechanisms involved in the clinical manifestations of the disease. In order to obtain insight into this unexplored aspect of Gaucher's disease, we examined the effects of glucocerebroside (GL(1)) at the cellular level in monolayers of cultured murine macrophages. The addition of GL(1) to these cultures stimulated the macrophages to release increased amounts of lymphocyte-activating factor (LAF) and lysosomal enzymes into the medium. These responses were proportional to the amount of GL(1) added to the culture. At higher levels of GL(1) (>/=20 mug/ml), lactic dehydrogenase, a cytoplasmic enzyme was also released indicating cellular damage at these doses. Intracellular LAF also increased in macrophages incubated with the high doses of GL(1), demonstrating an increase in total LAF production by these cells. Lipopolysaccharide acted synergistically with GL(1) and stimulated the release of exceedingly high levels of LAF which had a molecular weight profile similar to that of LAF released by exposure to lipopolysaccharide alone. Unlike GL(1), galactocerebroside, sphingomyelin, and ceramidetrihexoside, exerted little or no effect on the release of macrophage products. The effect of GL(1) was selective for macrophages since addition of this material to mouse lens epithelial cells had no detectable cytotoxic effect and it was only slightly toxic to lymphocytes or P815 cells in concentrations at which macrophages were clearly affected. A direct relationship was observed between the cytotoxicity of the sphingolipids and their accumulation in various cells. Macrophages accumulated large amounts of GL(1) but not sphingomyelin, whereas the other cells examined in this investigation did not accumulate either of these lipids. Human monocytes, like murine macrophages, also release increased amounts of LAF when incubated with GL(1). The effect of GL(1) was dose-responsive and synergy was found with lipopolysaccharide. The relevance of these findings to the pathogenesis of Gaucher's disease is considered.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6795230      PMCID: PMC370912          DOI: 10.1172/jci110363

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  25 in total

1.  SERUM LACTIC DEHYDROGENASE ACTIVITY: AN ANALYTICAL ASSESSMENT OF CURRENT ASSAYS.

Authors:  E AMADOR; L E DORFMAN; W E WACKER
Journal:  Clin Chem       Date:  1963-08       Impact factor: 8.327

Review 2.  Gaucher's disease, a review.

Authors:  S P Peters; R E Lee; R H Glew
Journal:  Medicine (Baltimore)       Date:  1977-09       Impact factor: 1.889

3.  Potentiation of the T lymphocyte response to mitogens. III. Properties of the mediator(s) from adherent cells.

Authors:  I Gery; R E Handschumacher
Journal:  Cell Immunol       Date:  1974-03-30       Impact factor: 4.868

Review 4.  Vertebrate rod outer segment membranes.

Authors:  F J Daemen
Journal:  Biochim Biophys Acta       Date:  1973-11-28

Review 5.  The heterocytotoxicity of human serum. I. Activation of the alternative complement pathway by heterologous target cells.

Authors:  D Eidinger; E Bello; A Mates
Journal:  Cell Immunol       Date:  1977-03-01       Impact factor: 4.868

6.  Tissue culture of lens epithelial cells from normal and Nakano mice.

Authors:  P Russell; H N Fukui; Y Tsunematsu; F L Huang; J H Konoshita
Journal:  Invest Ophthalmol Vis Sci       Date:  1977-03       Impact factor: 4.799

7.  Changes in cellular enzyme levels and extracellular release of lysosomal acid hydrolases in macrophages exposed to group A streptococcal cell wall substance.

Authors:  P Davies; R C Page; A C Allison
Journal:  J Exp Med       Date:  1974-05-01       Impact factor: 14.307

8.  Potentiation of the T-lymphocyte response to mitogens. I. The responding cell.

Authors:  I Gery; R K Gershon; B H Waksman
Journal:  J Exp Med       Date:  1972-07-01       Impact factor: 14.307

9.  Potentiation of the T-lymphocyte response to mitogens. II. The cellular source of potentiating mediator(s).

Authors:  I Gery; B H Waksman
Journal:  J Exp Med       Date:  1972-07-01       Impact factor: 14.307

10.  An examination of the cytotoxic effects of silica on macrophages.

Authors:  A C Allison; J S Harington; M Birbeck
Journal:  J Exp Med       Date:  1966-08-01       Impact factor: 14.307

View more
  7 in total

1.  Glucosylceramide and the level of the glucosidase-stimulating proteins.

Authors:  S C Datta; N S Radin
Journal:  Lipids       Date:  1986-11       Impact factor: 1.880

2.  Neonatal cholestasis as initial manifestation of type 2 Gaucher disease: a continuum in the spectrum of early onset Gaucher disease.

Authors:  Abdallah F Elias; Maria Ronningen Johnson; John K Boitnott; David Valle
Journal:  JIMD Rep       Date:  2011-12-11

3.  Effective treatment of painful bone crises in type I gaucher's disease with high dose prednisolone.

Authors:  I J Cohen; L Kornreich; S Mekhmandarov; K Katz; R Zaizov
Journal:  Arch Dis Child       Date:  1996-09       Impact factor: 3.791

4.  Stimulation of liver growth and DNA synthesis by glucosylceramide.

Authors:  S C Datta; N S Radin
Journal:  Lipids       Date:  1988-05       Impact factor: 1.880

5.  Efficient transfer and sustained high expression of the human glucocerebrosidase gene in mice and their functional macrophages following transplantation of bone marrow transduced by a retroviral vector.

Authors:  T Ohashi; S Boggs; P Robbins; A Bahnson; K Patrene; F S Wei; J F Wei; J Li; L Lucht; Y Fei
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-01       Impact factor: 11.205

6.  Elevation of serum beta-hexosaminidase and alpha-D-mannosidase in type 2 Gaucher disease: a clinical and biochemical study.

Authors:  D Chitayat; S Nakagawa; R W Marion; G S Sachs; S Shinnar; J F Llena; H M Nitowsky
Journal:  J Inherit Metab Dis       Date:  1987       Impact factor: 4.982

7.  Immunoglobulin and free light chain abnormalities in Gaucher disease type I: data from an adult cohort of 63 patients and review of the literature.

Authors:  M de Fost; T A Out; F A de Wilde; E P M Tjin; S T Pals; M H J van Oers; R G Boot; J F M G Aerts; M Maas; S Vom Dahl; C E M Hollak
Journal:  Ann Hematol       Date:  2008-02-15       Impact factor: 3.673

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.